Mount Sinai’s 15-Strain Gut Therapy Could Replace Fecal Transplants for C. diff
Fecal transplants work, but they come with real drawbacks: donor variability, pathogen risk, and no easy way to scale. A new Mount Sinai trial suggests a precisely engineered 15-strain bacterial therapy could change that.